NCT07883291 · NOT YET RECRUITING
SmartEnLite for Nursing Home Residents With Dementia
This trial tests a smart lighting system, SmartEnLite, in nursing homes. Researchers want to know if it improves mood, behaviors, and sleep in residents with dementia, compared with the facility's usual lighting. Residents wear a sleep sensor for 13 weeks. This is a device study with no phase, so it is not a drug trial and nothing is proven yet.
You may qualify if
- Age≥55
- English speaking
- Nursing home residency≥ 4 weeks
- Clinical Diagnosis of Alzheimer's Disease and related dementia
- Presence of agitation, depression, and/or apathy.
You're excluded if
- Major mental illness
- Severe vision impairment
- Severe acute or terminal illness
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-10-20